Arcus Biosciences, Gilead shares poob qis tom qab sib qhia cov ntaub ntawv hais txog cov tshuaj kho mob ntsws tshiab

Shares ntawm Arcus Biosciences Inc.
RCUS,
-27.76%
tau nqis 17.2% hauv kev ua lag luam ua ntej hnub Tuesday, hnub tom qab lub tuam txhab tau hais tias qhov kev sim kho mob rau cov qog nqaij hlav qog nqaij hlav tsis me me uas nws tab tom txhim kho nrog Gilead Sciences Inc.
Tsiaj,
-1.78%
txhim kho kev vam meej tsis muaj sia nyob thiab tag nrho cov lus teb [ORR] hauv Phase 2 kev tshawb fawb soj ntsuam. "Cov ntaub ntawv qhia meej meej tias qhov kev zov me nyuam siv tau, ua kom muaj kev cia siab rau lub tsev ua haujlwm nyob rau hauv qhov chaw mob qog noj ntshav loj, tab sis tus lej ORR yuav ua rau poob siab rau qee tus thiab nws tseem yuav pom ntau npaum li cas GILD / RCUS's combo tuaj yeem sib txawv tiag tiag vs. Ntxiv-ua ntej kev tswj hwm los ntawm ntau tus neeg tsim tau zoo hauv qhov chaw, "RBC Capital Markets tus kws tshuaj ntsuam Brian Abrahams tau sau rau hauv tsab ntawv ceeb toom rau cov neeg ua lag luam rau hnub Monday. Phab ntsa Street tau xav tias Arcus 'cov khoom lag luam yuav poob rau ntawm cov xov xwm, nrog SVB Securities kws tshuaj ntsuam Daina Graybosch qhia cov tub ua lag luam tias "cov tub lag luam bar tau nce zuj zus tuaj rau hauv cov ntaub ntawv no." Gilead cov khoom lag luam tseem poob qis, kwv yees li 2.6%, rau hnub Tuesday sawv ntxov. Arcus shares tau nqis 24.6% xyoo no, thaum lub dav S&P 500
SPX,
+ 0.34%
tau poob 19.9%.